Similar articles for PMID: 23411158

Year	Number of Results
2005	2
2006	5
2007	2
2008	4
2009	11
2010	17
2011	14
2012	11
2013	11
2014	12
2015	15
2016	6
2017	10
2018	6
2019	5
2020	12
2021	11
2022	4
2023	2
2024	1

1

Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.

Chistiakov DA, Sobenin IA, Orekhov AN. Chistiakov DA, et al. Immunol Lett. 2013 Mar;151(1-2):10-22. doi: 10.1016/j.imlet.2013.01.014. Epub 2013 Feb 11. Immunol Lett. 2013. PMID: 23411158 Review.

2

Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.

Meier P, Meier R, Blanc E. Meier P, et al. Expert Rev Cardiovasc Ther. 2008 Aug;6(7):987-97. doi: 10.1586/14779072.6.7.987. Expert Rev Cardiovasc Ther. 2008. PMID: 18666849 Review.

3

Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.

Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A. Dinh TN, et al. Circulation. 2012 Sep 4;126(10):1256-66. doi: 10.1161/CIRCULATIONAHA.112.099044. Epub 2012 Jul 31. Circulation. 2012. PMID: 22851544

4

Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.

Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, Yu K, Shi H, Zhu R, Mao X. Zhong Y, et al. Clin Exp Immunol. 2016 Mar;183(3):452-68. doi: 10.1111/cei.12726. Epub 2015 Nov 24. Clin Exp Immunol. 2016. PMID: 26452441 Free PMC article.

5

Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR. Huang H, et al. J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446. Epub 2010 Sep 24. J Immunol. 2010. PMID: 20870943

6

Treating atherosclerosis with regulatory T cells.

Foks AC, Lichtman AH, Kuiper J. Foks AC, et al. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7. doi: 10.1161/ATVBAHA.114.303568. Epub 2014 Nov 20. Arterioscler Thromb Vasc Biol. 2015. PMID: 25414253 Free PMC article. Review.

7

FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.

Dummer CD, Carpio VN, Gonçalves LF, Manfro RC, Veronese FV. Dummer CD, et al. Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13. Transpl Immunol. 2012. PMID: 21939765 Review.

8

Regulatory T cells as a new therapeutic target for atherosclerosis.

Ou HX, Guo BB, Liu Q, Li YK, Yang Z, Feng WJ, Mo ZC. Ou HX, et al. Acta Pharmacol Sin. 2018 Aug;39(8):1249-1258. doi: 10.1038/aps.2017.140. Epub 2018 Jan 11. Acta Pharmacol Sin. 2018. PMID: 29323337 Free PMC article. Review.

9

Aspirin may do wonders by the induction of immunological self-tolerance against autoimmune atherosclerosis.

Hussain M, Javeed A, Ashraf M, Riaz A, Mushtaq MH. Hussain M, et al. Med Hypotheses. 2012 Jan;78(1):171-3. doi: 10.1016/j.mehy.2011.10.019. Epub 2011 Nov 8. Med Hypotheses. 2012. PMID: 22070887

10

Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.

Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Yamazaki S, et al. Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year